Stay updated on Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.

Latest updates to the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated to v3.7.0. This indicates a deployment/version update to the page template and underlying systems rather than any new or altered study information visible to users.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page shows a revision bump from v3.6.5 to v3.6.6, indicating a minor platform/template update behind the page. This does not reflect a change in the study details or displayed information.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. There are no changes to the study details or visible content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Publications section now includes a finalized citation for the cfDNA end-motif entropy immunotherapy study (Revision: v3.6.4) and removes the previous 'Online ahead of print' citation (Revision: v3.6.3).SummaryDifference0.1%

- Check81 days agoChange DetectedThe page's revision tag changed from v3.6.0 to v3.6.3, signaling a software update to the page. This is a behind-the-scenes version bump and does not modify displayed study information.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page now shows a 'No longer looking for participants' notice and adds guidance sections like 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' heading is updated/added while the old 'Intervention / Treatment' heading is removed, and the revision note changes from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.